← Back to headlines
Merck Strikes Nearly $6 Billion Deal to Acquire Cancer Biotech Terns
Pharmaceutical giant Merck has reached an agreement for a deal valued at nearly $6 billion to acquire Terns, a biotechnology company focused on cancer research.
26 Mar, 08:02 — 26 Mar, 08:02
Sources
Showing 1 of 1 sources
Related Stories
Philippine Charity Sweepstakes Office Provides ₱18.2M Aid to Mindoro Healthcare
just now
NGO Provides Health Insurance for Pregnant Women in Enugu
just now
Philippines clears irrigation canals in Bicol to mitigate El Niño impact
just now
Kwara State Government Pledges Improved Immunisation Efforts
just now